GlassScriptPhysician profile
Jillian Wang Colson
NPI 1063830982
$2,221.02
in general payments reported to CMS, 2019-2025
11 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $108 · 2021: $122 · 2022: $918 · 2023: $163 · 2024: $95.34 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $859.22 | 2019-2024 | Hydrus Microstent, Centurion |
| Glaukos Corporation | $422.33 | 2019-2025 | Istent Inject Trabecular Micro-Bypass System, Istent Infinite, Idosetr |
| Novartis Pharmaceuticals Corporation | $240.16 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $147.27 | 2019-2023 | Tecnis Iol |
| Mallinckrodt Hospital Products INC. | $145.81 | 2025 | Acthar |
| Rxsight INC | $134.40 | 2022 | |
| Dompe US, INC. | $124.98 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $98.72 | 2022-2024 | Callisto Eye |
| Sight Sciences, INC. | $27.74 | 2020-2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $19.56 | 2022 | |
| Travere Therapeutics, INC. | $0.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Colson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.